BBY:NYSEBest Buy Co., Inc. Analysis
Data as of 2026-03-13 - not real-time
$62.59
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Best Buy posted a solid earnings beat, delivering EPS above analyst expectations while revenue was marginally shy of forecasts, which ignited fresh analyst coverage and a short‑term price rally. Technical indicators show the stock trading below its 20‑day and 50‑day moving averages, with a bearish MACD crossover and RSI in the mid‑40s, suggesting lingering downside pressure despite the recent bounce. The dividend yield remains attractive at over 6%, and the payout ratio, while high, is supported by robust operating cash flow and positive free cash flow. However, the discounted cash‑flow model values the company at roughly half its current market price, indicating that the market may be pricing in optimistic growth assumptions that are not fully justified by the fundamentals.
Given the blend of strong cash generation, an appealing dividend, and an overvalued price relative to intrinsic estimates, investors should weigh the short‑term upside from earnings momentum against the longer‑term valuation gap and sector cyclicality. Maintaining a cautious stance—favoring income and stability while monitoring price action around key support levels—aligns with the current risk‑reward profile.
Given the blend of strong cash generation, an appealing dividend, and an overvalued price relative to intrinsic estimates, investors should weigh the short‑term upside from earnings momentum against the longer‑term valuation gap and sector cyclicality. Maintaining a cautious stance—favoring income and stability while monitoring price action around key support levels—aligns with the current risk‑reward profile.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Recent earnings beat and momentum rally
- Attractive dividend yield
- Price near technical support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Current market price exceeds intrinsic DCF valuation
- Stable cash flow generation supporting dividend
- Bearish technical backdrop limiting upside
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High valuation relative to fundamentals
- Consumer‑cyclical exposure to economic cycles
- Sustainable dividend providing income return
Key Metrics & Analysis
Financial Health
Revenue Growth-1.00%
Profit Margin2.56%
P/E Ratio12.4
ROE37.04%
ROA7.52%
Debt/Equity139.44
P/B Ratio4.4
Op. Cash Flow$2.0B
Free Cash Flow$689.5M
Technical Analysis
TrendBearish
RSI41.4
Support$60.51
Resistance$68.38
MA 20$64.43
MA 50$66.31
MA 200$71.61
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$33.17
Target Price$74.85
Upside/Downside19.59%
GradeOvervalued
TypeValue
Dividend Yield6.13%
Risk Assessment
Beta1.40
Volatility38.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.